机译:Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
Hospital CUF Tejo;
Hospital Pedro Hispano (Unidade Local de Saúde de Matosinhos);
Hospital do Espírito Santo de évoraMedical oncology department,Instituto Português de Oncologia Do PortoHospital de Santo António Dos Capuchos (Centro Hospitalar Universitário de Lisboa Central)Instituto Português de Oncologia de CoimbraHospital de S?o Jo?o (Centro Hospitalar Universitário de S?o Jo?o);
Advanced or metastatic renal cell carcinoma (mRCC); Immune checkpoint inhibitor (ICI); Monotherapy; Tyrosine kinase inhibitor (TKI);